Active, not recruitingPhase 3NCT04576117
A Study to Compare Treatment With the Drug Selumetinib Alone Versus Selumetinib and Vinblastine in Patients With Recurrent or Progressive Low-Grade Glioma
Studying Low-grade astrocytoma
Last synced from ClinicalTrials.gov
ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing dataKey facts
- Sponsor
- National Cancer Institute (NCI)
- Principal Investigator
- Daniel C BowersChildren's Oncology Group
- Intervention
- Biospecimen Collection(procedure)
- Enrollment
- 300 enrolled
- Eligibility
- 2-25 years · All sexes
- Timeline
- 2021 – 2026
Study locations (20)
- Children's Hospital of Alabama, Birmingham, Alabama, United States
- Arkansas Children's Hospital, Little Rock, Arkansas, United States
- Loma Linda University Medical Center, Loma Linda, California, United States
- Children's Hospital Los Angeles, Los Angeles, California, United States
- Kaiser Permanente-Oakland, Oakland, California, United States
- Children's Hospital of Orange County, Orange, California, United States
- Lucile Packard Children's Hospital Stanford University, Palo Alto, California, United States
- Children's Hospital Colorado, Aurora, Colorado, United States
- Connecticut Children's Medical Center, Hartford, Connecticut, United States
- Yale University, New Haven, Connecticut, United States
- Alfred I duPont Hospital for Children, Wilmington, Delaware, United States
- Children's National Medical Center, Washington D.C., District of Columbia, United States
- Golisano Children's Hospital of Southwest Florida, Fort Myers, Florida, United States
- UF Health Cancer Institute - Gainesville, Gainesville, Florida, United States
- Memorial Regional Hospital/Joe DiMaggio Children's Hospital, Hollywood, Florida, United States
- +5 more locations on ClinicalTrials.gov
Primary source
Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.
Open NCT04576117 on ClinicalTrials.govOther trials for Low-grade astrocytoma
Additional recruiting or active studies for the same condition.